Sugi Predict

Sugi Predict / Compounds / SCHEMBL5414474

SCHEMBL5414474

SCHEMBL5414474

c1ccc(-c2cccc3c4nc5nc(nc6[nH]c(nc7nc(nc([nH]4)c23)-c2ccccc2-7)c2ccccc62)-c2ccccc2-5)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK4 Q9HAZ1 3/20 0.41
▸ LIMK1 P53667 2/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ PDGFRA P16234 1/20 0.41
▸ LTK P29376 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ MAPK8 P45983 1/20 0.41
▸ CSNK1A1 P48729 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41
▸ TNK2 Q07912 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41
▸ DYRK1B Q9Y463 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ APEX1 P27695 1/20 0.40
▸ RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7616729 0.91 TDP1 (0.43) CLK4LIMK1MAP4K4CSF1RFGFR1
SCHEMBL7455206 0.90 MEN1 (0.40) CLK4CDK5TDP1MEN1THRB
SCHEMBL27501031 0.88 MEN1 (0.36) CLK4LIMK1MAP4K4CSF1RFGFR1
SCHEMBL27682830 0.88 KDR (0.41) CLK4LIMK1MAP4K4CSF1RFGFR1
SCHEMBL27736611 0.87 MEN1 (0.46) KDRCDK5ACVR1TDP1MEN1
SCHEMBL4960846 0.85 TSHR (0.43) CLK4LIMK1MAP4K4CSF1RFGFR1
Ciaftalan SCHEMBL5414467 0.85 MEN1 (0.45) CLK4CDK5TDP1MEN1THRB
SCHEMBL815462 0.84 ALDH1A1 (0.48) TDP1MEN1THRBAPEX1RECQL
SCHEMBL27755029 0.84 GSK3B (0.39) CDK5TDP1MEN1THRBAPEX1
SCHEMBL9296537 0.83 ALDH1A1 (0.47) TDP1MEN1THRBAPEX1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4033980-A Phthalocyanine dyestuffs and process for preparing them HOECHST AKTIENGESELLSCHAFT (DT) 1977-07-05 — — US claimed
US-20230373130-A1 OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF XEROX CORPORATION (US) 2023-11-23 — — US disclosed
US-11801617-B2 Optical absorbing thermoplastic polymer particles and methods of production and uses thereof XEROX CORPORATION (US) 2023-10-31 — — US disclosed
CN-112521768-A Oil-soluble dye, preparation method and application thereof 大连理工大学 2021-03-19 — — CN disclosed
US-20210069935-A1 OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF XEROX CORPORATION (US) 2021-03-11 — — US disclosed
EP-3789429-A1 OPTICAL ABSORBING THERMOPLASTIC POLYMER PARTICLES AND METHODS OF PRODUCTION AND USES THEREOF Xerox Corporation (US) 2021-03-10 — — EP disclosed
CN-112457319-A Oil-soluble photosensitizer, preparation method and application thereof 大连理工大学 2021-03-09 — — CN disclosed
CN-102449795-B Use of phthalocyanine compounds with aryl or hetaryl substituents in organic solar cells BASF SE 2015-06-10 — — CN disclosed
CN-102449795-A Use of phthalocyanine compounds with aryl or heteroaryl substituents in organic solar cells BASF SE 2012-05-09 — — CN disclosed
US-7276494-B2 Photosensitisers PHOTOPHARMICA LIMITED (GB) 2007-10-02 — — US disclosed
US-6837918-B2 Process for the manufacture of nanoparticle organic pigments AVEKA, INC. (US) 2005-01-04 — — US disclosed
US-20030180224-A1 Photosensitisers PHOTOPHARMICA LIMITED 2003-09-25 — — US disclosed
US-20030134824-A1 Beta-cyclodextrin dimers and phthalocyanines and uses thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2003-07-17 — — US disclosed
WO-2003053614-A1 A PROCESS FOR THE MANUFACTURE OF REACTED ALUMINUM OR COPPER NANOPARTICLES AVEKA, INC. (US) 2003-07-03 — — WO disclosed
US-20030116017-A1 Process for the manufacture of nanoparticle organic pigments AVEKA, INC. 2003-06-26 — — US disclosed
WO-2003052060-A2 BETA-CYCLODEXTRIN DIMERS AND PHTHALOCYANINES AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2003-06-26 — — WO disclosed
EP-0343796-B1 Pigment dispersions MINNESOTA MINING & MFG (US) 1996-03-06 — — EP disclosed
US-5106533-A Ultrafine particles dispersed in aqueous and nonaqueous media; contact lenses with perfluoropolyether segments and copper phthalocyanine particles MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-04-21 — — US disclosed
US-5030669-A Vaporization of a pigment or precursor in the presence of a nonreactive, or reactive, gas, repectively, and transporting the ultrafine particles to a dispesion medium MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-07-09 — — US disclosed
EP-0343796-A2 Pigment dispersions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-11-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030180224-A1 Photosensitisers PPOX, UACA, PTDSS1 CLK4 3346/4885LIMK1 4366/4885MAP4K4 1923/4885
US-20030134824-A1 Beta-cyclodextrin dimers and phthalocyanines and uses thereof CRY2, CRY1, HCCS CLK4 767/4885LIMK1 1750/4885MAP4K4 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.